CombiChem, ImClone deal

The companies will collaborate to discover and develop small molecules active against selected cancer targets.

Read the full 150 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE